Studies have highlighted the role of particular ILs, such as IL-1, IL-6, and IL-11, in enhancing osteoclastogenesis, tumor growth, and bone deterioration, underscoring their potential as targets for therapeutic intervention to hinder bone metastases [26]. The gene discussed is IL1A; the disease is neoplasm.